Women's health is siloed — and that's why she keeps falling through the gaps

What just happened

New data published through RACGP newsGP this week puts numbers to something that has been visible in consulting rooms for a long time. In 2026, half of all Australian women experience mental health issues. One in four experience severe psychological distress. These are not marginal figures. They describe the lived experience of the majority of women in this country.

The data also shows the gap between recognising a problem and being able to act on it. Sixty-six percent of women with mental health issues sought help in 2026 — up from 57% the year before. But the proportion using GP mental health support dropped significantly: 74% of women visited a GP for mental health in 2025; in 2026 that fell to 49%. The most cited reason for not accessing care: cost. Thirty-one percent of women named cost as the main barrier to seeing a GP for mental health support.

If the system is becoming more expensive to access and help-seeking is dropping in parallel, that is not a patient behaviour problem. That is an access problem.

Both-and

The data names fragmentation as the structural cause

Associate Professor Magdalena Simonis described it exactly: “From adolescence to late life, at each hormonal transition a woman presents to a health system built around single episodes, not a continuous life story.” That sentence contains the diagnosis.

The Australian healthcare system structures mental health care separately from physical health care. Referral pathways, Medicare billing items, specialist training, and clinical protocols treat gynaecological conditions in one lane and mood disorders in another. The woman with endometriosis and treatment-resistant depression does not have two problems. She has one complex physiological state that presents in two clinical languages — and the system is not designed to speak both at once.

Women with female-specific physical conditions — endometriosis, polycystic ovary syndrome, perimenopausal hormonal dysregulation — experience significantly greater psychological distress than women without them. This is not coincidental. Oestrogen, progesterone, and testosterone all modulate serotonin, dopamine, and GABA — the neurotransmitter systems that govern mood and sleep. When hormonal systems are disrupted, these neurotransmitter systems are disrupted too. The link is physiological, not circumstantial.

Yet the clinical response to a woman presenting with depression during perimenopause is often to assess the mood and the hormones as independent events — a psychiatrist for one, a gynaecologist for the other, a GP attempting to translate between them.

What the data does and does not tell us

The drop from 74% to 49% of women using GP mental health support year-on-year is striking, but it needs careful reading. It may reflect expanded use of other pathways — direct-access psychology, digital mental health platforms, telehealth services. It may also reflect that when a service becomes less affordable, people stop using it — not because they are better, but because the barrier is too high.

Twenty-three percent of women dissatisfied with their mental health care cited a lack of tailored women-specific services. Another 23% cited inadequate support from their clinician. Depression was the top reported issue at 30%, followed by anxiety at 21%, body image concerns at 20%, and insomnia at 16%. The top stressors were financial pressure (34%), low self-esteem (34%), sleep problems (32%), self-imposed pressure (29%), and ageing (24%).

None of these are simple clinical categories. Many of them are interconnected. A system designed around episodic, single-problem consultations is not well suited to a woman carrying several of them simultaneously — particularly when the underlying hormonal driver touches all of them at once.

The GP visit as a data point, not a resolution

It is worth naming what a GP visit for mental health is, and is not, in this dataset. The 49% figure does not tell us what happened in those consultations. A GP visit may result in a Mental Health Treatment Plan, a referral to a psychologist, a prescription, or a conversation that helps the patient understand what is happening and what her options are. It may also — depending on the GP and the consultation — result in none of these.

The 50% of women who found their GP visit “very helpful” and the 54% who found medication helpful are real signals that GP-led mental health care can work. The 23% who cited inadequate clinician support suggest it is not working consistently. The difference is often not the clinician’s intent — it is the time, training, and system design the clinician is working within.

2 cents

The connection between a woman’s hormonal timeline and her mental health experience is not a coincidence, and it is not a mystery — it is physiology. If the care she has received has treated her depression as though it arrived independently of her perimenopause, her endometriosis, or her postpartum recovery, the missing link is not in her. It is in how the consultation was framed.

A GP who understands the cross-terrain of women’s hormonal and mental health can assess both in the same room. The RACGP’s recommendations include gender-responsive workforce training and funded national telehealth pathways specifically for this population — structural changes that take time to implement. The individual consultation doesn’t have to wait.

This is general information. Whether any of this framing applies to a specific person’s situation — and what to do about it — is a conversation, not an article.

Verdict: yes — worth knowing about. One in two Australian women. The data is not describing an outlier group. The system design that produces these outcomes warrants examination.

---

Sources cited

1. Siloed women’s physical and mental health care impacting outcomes. RACGP newsGP, 9 September 2026.